Nucleic Acids Research, 1994, Vol. 22, No. 12 2242-2248
© 1994
RNA |
Reduced ß2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme
Unit for Molecular Genetics, Center for Biotechnology, Karolinska Institute Novum, 141 57 Huddinge, Sweden
*To whom correspondence should be addressed
Received April 8, 1994. Revised May 25, 1994. Accepted May 25, 1994.
We have generated three artificial hammerhead ribozymes, denoted Rz-b, Rz-c and Rz-d, with different specificities for exon II of the mouse beta-2-microglobulin (ß2M) mRNA. In this study we tested for ribozyme mediated reduction of ß2M mRNA in a cell line and in transgenic mice. Transfections of either of the Rz-b, Rz-c or Rz-d plasmids into a mouse cell-line (NIH/3T3) revealed reductions of ß2M mRNA substrate in each case. Ribozyme expression in individual transfected clones was accompanied with an up to 80% reduction of ß2M mRNA levels. Rz-c was selected for a transgenic study. Seven Rz-c transgenic founder animals were identified from which three ribozyme expressing families were established and analysed. Expression of the ribozyme transgene was tested for and detected in lung, kidney and spleen. Expression was accompanied with reduction of the ß2M mRNA levels of heterozygous (Rz +/) animals compared to non-transgenic litter mates. The effect was most pronounced in lung with more than 90% ß2M mRNA reduction in individual mice. In summary, expression of our ribozymes in a cell free system, in a cell-line and in transgenic mice were all accompanied with reductions of ß2M mRNA levels.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Bockamp, M. Maringer, C. Spangenberg, S. Fees, S. Fraser, L. Eshkind, F. Oesch, and B. Zabel Of mice and models: improved animal models for biomedical research Physiol Genomics, December 3, 2002; 11(3): 115 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, D. W. Ohannesian, E. L. Kreklau, and L. C. Erickson Modulation of 1,3-Bis-(2-chloroethyl)-1-nitrosourea Resistance in Human Tumor Cells Using Hammerhead Ribozymes Designed to Degrade O6-Methylguanine DNA Methyltransferase mRNA J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 141 - 147. [Abstract] [Full Text] |
||||
![]() |
M. Andang, J. Hinkula, G. Hotchkiss, S. Larsson, S. Britton, F. Wong-Staal, B. Wahren, and L. Ahrlund-Richter Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model PNAS, October 26, 1999; 96(22): 12749 - 12753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Wang, M. Enjoji, M. Tiebel, S. Ochsner, L. Chan, and B.-B. Teng Hammerhead Ribozyme Cleavage of Apolipoprotein B mRNA Generates a Truncated Protein J. Biol. Chem., August 20, 1999; 274(34): 24161 - 24170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iida and S. Kobayashi Essential role of mitochondrially encoded large rRNA for germ-line formation in Drosophila embryos PNAS, September 15, 1998; 95(19): 11274 - 11278. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. James and I. Gibson The Therapeutic Potential of Ribozymes Blood, January 15, 1998; 91(2): 371 - 382. [Abstract] [Full Text] [PDF] |
||||




